Liren Liu

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 4

Top Topics

Liver Metastases

Advanced Non Small Cell Lung Cancer

Diffusion Weighted Imaging

Signaling Pathway

Top Venues

Cancer medicine

Chinese medicine

Tianjin Medical University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Tianjin Medical University Dec 01 2015

China

Professor :: GI Cancer Biology

Tianjin Medical University Oct 01 2014 - Dec 01 2015

China

Associate Professor :: GI Cancer Biology

Weill Cornell Medical College May 01 2013 - Sep 01 2014

United States

Research Assistant Professor :: pathology

Weill Cornell Medical College Sep 01 2007 - May 01 2013

United States

Research Associate :: pathology

Publications

Jun Zhao, Boyu Pan, Xinglu Zhou, Chunnuan Wu, Fengcheng Hao, Jie Zhang, Liren Liu
Polygonum cuspidatum inhibits the growth of osteosarcoma cells via impeding Akt/ERK/EGFR signaling pathways. Bioengineered 13 (2) (2022)
Boyu Pan, Yafei Xia, Zilu Gao, Gang Zhao, Liangjiao Wang, Senbiao Fang, Liren Liu, Shu Yan
Cinnamomi Ramulus inhibits the growth of colon cancer cells via Akt/ERK signaling pathways. Chinese medicine 17 (1) (2022)
Zhong-Guo Zhang, Fei Ma, Shuang Zhao, Xiaoyu Yang, Fang Liu, Chenghai Xue, Liren Liu, Jin Gu, Haozhe Piao
Effects of somatic alterations at pathway level are more mechanism-explanatory and clinically applicable to quantity of liver metastases of colorectal cancer. Cancer medicine 8 (10) (2019)
Ying Fu, Gang Ma, Guolong Liu, Bin Li, Hui Li, Xishan Hao, Liren Liu
USP14 as a novel prognostic marker promotes cisplatin resistance via Akt/ERK signaling pathways in gastric cancer. Cancer medicine 7 (11) (2018)